Science Applications Inte... (SAIC)
101.65
-0.98 (-0.95%)
At close: Mar 06, 2025, 11:03 AM
Science Applications International Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Revenue | 7.44B | 7.7B | 7.39B | 7.06B | 6.38B | 4.66B | 4.45B | 4.45B | 4.32B | 3.88B | 4.12B | 11.17B | 10.59B | 10.8B | 10.58B |
| Cost of Revenue | 6.57B | 6.82B | 6.54B | 6.26B | 5.67B | 4.2B | 4.04B | 4B | 3.9B | 3.55B | 3.79B | 9.81B | 9.61B | 9.37B | 9.15B |
| Gross Profit | 872M | 888M | 859M | 792M | 706M | 464M | 411M | 447M | 411M | 335M | 333M | 1.36B | 981M | 1.42B | 1.43B |
| Operating Income | 741M | 501M | 462M | 390M | 370M | 220M | 256M | 271M | 227M | 240M | 183M | 734M | 311M | 929M | 836M |
| Interest Income | n/a | 120M | 105M | 122M | 90M | n/a | n/a | n/a | n/a | n/a | n/a | 10M | 5M | 2M | 2M |
| Pretax Income | 620M | 375M | 358M | 271M | 286M | 170M | 214M | 220M | 183M | 223M | 176M | 659M | 202M | 839M | 746M |
| Net Income | 477M | 300M | 277M | 209M | 226M | 137M | 179M | 148M | 117M | 141M | 113M | 526M | 56M | 611M | 482M |
| Selling & General & Admin | 373M | 374M | 344M | 352M | 288M | 158M | 155M | 166M | 158M | 95M | 92M | 592M | 670M | 495M | 593M |
| Research & Development | n/a | 9M | 13M | 14M | 18M | 5M | 4M | 4M | 4M | 5M | 4M | 3M | n/a | n/a | n/a |
| Other Expenses | -242M | -6M | -3M | -4M | 6M | 3M | 2M | 1M | 26M | n/a | n/a | 8M | 5M | 2M | 6M |
| Operating Expenses | 131M | 374M | 341M | 348M | 288M | 158M | 155M | 166M | 158M | 95M | 92M | 592M | 670M | 495M | 593M |
| Interest Expense | 120M | 120M | 105M | 122M | 90M | 53M | 44M | 52M | 44M | 17M | 7M | 93M | 119M | 94M | 98M |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -1M | 11M | -6M | 4M | 5M | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 6.7B | 7.19B | 6.88B | 6.61B | 5.96B | 4.35B | 4.2B | 4.17B | 4.06B | 3.65B | 3.88B | 10.4B | 10.28B | 9.87B | 9.74B |
| Income Tax | 143M | 72M | 79M | 60M | 57M | 33M | 35M | 72M | 66M | 82M | 63M | 135M | 213M | 300M | 281M |
| Shares Outstanding (Basic) | 53.1M | 55.3M | 57.6M | 58.1M | 58.4M | 43.4M | 43.3M | 44.5M | 45.8M | 46.9M | 48.6M | 329M | 329M | 338M | 338M |
| Shares Outstanding (Diluted) | 53.7M | 55.8M | 58.1M | 58.7M | 59M | 44.1M | 44.5M | 45.9M | 47.4M | 48.5M | 49.7M | 329M | 329M | 339M | 339M |
| EPS (Basic) | 8.98 | 5.43 | 4.81 | 3.60 | 3.87 | 3.16 | 4.13 | 3.21 | 2.55 | 3.01 | 2.33 | 0.55 | 0.55 | 1.81 | 1.43 |
| EPS (Diluted) | 8.88 | 5.38 | 4.77 | 3.56 | 3.83 | 3.11 | 4.02 | 3.12 | 2.47 | 2.91 | 2.27 | 0.55 | 0.55 | 1.80 | 1.42 |
| EBITDA | 882M | 665M | 684M | 626M | 507M | 270M | 304M | 317M | 227M | 261M | 196M | 322M | 313M | 1.04B | 934M |
| Depreciation & Amortization | 142M | 157M | 165M | 179M | 131M | 47M | 44M | 50M | 59M | 21M | 13M | 113M | 114M | 110M | 90M |